https://www.selleckchem.com/products/Irinotecan-Hcl-Trihydrate-Campto.html Obesity is an epidemic in New York City, the global epicenter of the coronavirus pandemic. Previous studies suggest that obesity is a possible risk factor for adverse outcomes in COVID-19. To elucidate the association between obesity and COVID-19 outcomes. Retrospective cohort study of COVID-19 hospitalized patients tested between March 10 and April 13, 2020. SUNY Downstate Health Sciences University, a COVID-only hospital in New York. In total, 684 patients were tested for COVID-19 and 504 were analyzed. Patients were categorized into three groups by BMI normal (BMI 18.50-24.99), overweight (BMI 25.00-29.99), and obese (BMI ≥ 30.00). Primary outcome was 30-day in-hospital mortality, and secondary outcomes were intubation, acute kidney injury (AKI), acute respiratory distress syndrome (ARDS), and acute cardiac injury (ACI). There were 139 patients (27%) with normal BMI, 150 patients who were overweight (30%), and 215 patients with obesity (43%). After controlling for age, gender, diabetes, hyper19 are at increased risk for mortality and intubation compared to those with normal BMI. These findings support the hypothesis that obesity is a risk factor for COVID-19 complications and should be a consideration in management of COVID-19. To implement an "Empathy Workshop" focused on improving Neonatal Intensive Care Unit (NICU) health care provider communication skills. Staff-led, small group "Empathy Workshops" were conducted over a 2 year period. NICU parents answered a section of the "Picker Institute Parent Experiences of Neonatal Care Survey" in the pre- and post-intervention periods. NICU health care providers completed the "NICU Provider Communication Skills Self-Assessment" at three time points. Parent survey scores significantly improved in two questions referring to child by first name (p = 0.02) and being offered emotional support from the staff (p = 0.03) or information on parent support